BioVie Inc - ESG Rating & Company Profile powered by AI
The Disclosure score includes seventeen UN Sustainable Development Goals including: 'Good Health & Wellbeing', 'Reduced Inequalities' and 'Life on Land'. If you are employed by BioVie Inc and you would like to use your ESG rating, please contact us. The page contains a questions and answers section on BioVie Inc.
BioVie Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.6; made up of an environmental score of 0.0, social score of 3.2 and governance score of 1.6.
1.6
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1682 | Viracta Therapeutics Inc | 1.7 | Low |
| 1682 | Werewolf Therapeutics Inc | 1.7 | Low |
| 1715 | BioVie Inc | 1.6 | Low |
| 1715 | CareDx Inc | 1.6 | Low |
| 1715 | Catalyst Biosciences Inc | 1.6 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does BioVie Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes BioVie Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes BioVie Inc report the average age of the workforce?
Sign up for free to unlockDoes BioVie Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes BioVie Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes BioVie Inc disclose cybersecurity risks?
Sign up for free to unlockDoes BioVie Inc offer flexible work?
Sign up for free to unlockDoes BioVie Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes BioVie Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes BioVie Inc conduct supply chain audits?
Sign up for free to unlockDoes BioVie Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes BioVie Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes BioVie Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes BioVie Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes BioVie Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes BioVie Inc disclose water use targets?
Sign up for free to unlockDoes BioVie Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid BioVie Inc have a product recall in the last two years?
Sign up for free to unlockDoes BioVie Inc disclose incidents of discrimination?
Sign up for free to unlockDoes BioVie Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas BioVie Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes BioVie Inc disclose parental leave metrics?
Sign up for free to unlockDoes BioVie Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes BioVie Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes BioVie Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes BioVie Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes BioVie Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes BioVie Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs BioVie Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes BioVie Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes BioVie Inc disclose its waste policy?
Sign up for free to unlockDoes BioVie Inc report according to TCFD requirements?
Sign up for free to unlockDoes BioVie Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes BioVie Inc disclose energy use targets?
Sign up for free to unlockDoes BioVie Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes BioVie Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for BioVie Inc
These potential risks are based on the size, segment and geographies of the company.
BioVie Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of chronic debilitating conditions in the United States. Its products pipeline includes BIV201, which completed Phase IIa clinical trial for the treatment of ascites caused due to chronic liver cirrhosis; and NE3107, a potentially selective inhibitor of inflammatory extracellular single-regulated kinase, which is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease, as well as Phase 2 clinical trial for the treatment of Parkinson's disease. The company is also developing NE3107, which is in pre-clinical stage for the treatment of multiple myeloma and prostate cancer. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.